Abivax (ABVX) Other Non-Current Assets (2022 - 2025)

Abivax's (ABVX) quarterly Other Non-Current Assets came in at $727527.2 in Q4 2025, down 88.5% year-on-year from $6.3 million in Q4 2024, and down 19.39% quarter-over-quarter from $902516.8 in Q1 2025.

Abivax (ABVX) Other Non-Current Assets (2022 - 2025) Analysis & Trends

Abivax's Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $727527.2 for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets fell 88.5% year-over-year to $727527.2 in Q4 2025; TTM through Dec 2025 was $727527.2, a 88.5% decrease from a year earlier, with the FY2025 full-year figure at $727527.2, down 88.64% from the prior year.
  • Other Non-Current Assets fell to $727527.2 in Q4 2025 per ABVX's latest filing, from $902516.8 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $6.3 million in Q4 2024 and bottomed at $727527.2 in Q4 2025.
  • The 4-year median for Other Non-Current Assets is $1.1 million (2022), against an average of $2.1 million.
  • Across the five-year window, Other Non-Current Assets soared 153.39% in 2024 and tumbled 88.5% in 2025, its largest moves.
  • Year by year, Other Non-Current Assets stood at $1.1 million in 2022, then jumped by 135.93% to $2.5 million in 2023, then surged by 153.39% to $6.3 million in 2024, then tumbled by 88.5% to $727527.2 in 2025.
  • Per Business Quant, the three latest ABVX Other Non-Current Assets figures stand at $727527.2 (Q4 2025), $902516.8 (Q1 2025), and $6.3 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 1.02 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 60,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 104.24 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 289.41 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 14.48 Mn
10 Abivax 9.98 Bn 9.98 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 727,527.20
Mar 31, 2025 902,516.85
Dec 31, 2024 6.33 Mn
Jun 30, 2024 1.21 Mn
Dec 31, 2023 2.50 Mn
Dec 31, 2022 1.06 Mn